Terms: = Leukemia AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Diagnosis
123 results:
1. [Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy].
Wang LL; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):845-850. PubMed ID: 38049337
[No Abstract] [Full Text] [Related]
2. A comparative safety review of targeted therapies for acute myeloid leukemia.
Dalgetty M; Leurinda C; Cortes J
Expert Opin Drug Saf; 2023; 22(12):1225-1236. PubMed ID: 38014918
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Mutation Profiles of Patients with Acute Myeloid leukemia in Korea: a Single-Center Experience.
Han E; Ryu S; Kim D; Koh EH; Byun JH; Lee DH
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948498
[TBL] [Abstract] [Full Text] [Related]
4. MLPA in the initial genetic screening of patients with acute myeloid leukemia.
Yahya D; Hachmeriyan M; Ruseva T; Chervenkov T; Micheva I
Rom J Intern Med; 2024 Mar; 62(1):44-51. PubMed ID: 37948316
[TBL] [Abstract] [Full Text] [Related]
5. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
Tefferi A; Alkhateeb H; Gangat N
Blood Cancer J; 2023 Jul; 13(1):108. PubMed ID: 37460550
[TBL] [Abstract] [Full Text] [Related]
6. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management.
Tefferi A; Barbui T
Am J Hematol; 2023 Sep; 98(9):1465-1487. PubMed ID: 37357958
[TBL] [Abstract] [Full Text] [Related]
7. Real-world genomic profiling of acute myeloid leukemia and the impact of European leukemiaNet risk stratification 2022 update.
da Rosa SEA; de Lima LB; Silveira CN; Cortes LGF; de Oliveira Filho JB; de Souza Reis R; Cervato MC; Rodrigues PHS; de Oliveira Pelegrino K; Petroni RC; da Silva Araujo E; Campregher PV
Clin Transl Oncol; 2023 Dec; 25(12):3431-3436. PubMed ID: 37165281
[TBL] [Abstract] [Full Text] [Related]
8. Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician.
Lai C; Bhansali RS; Kuo EJ; Mannis G; Lin RJ
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390018. PubMed ID: 37155946
[TBL] [Abstract] [Full Text] [Related]
9. The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia.
Chen X; Tian C; Hao Z; Pan L; Hong M; Wei W; Muyey DM; Wang H; Chen X
Cancer Med; 2023 May; 12(9):10340-10350. PubMed ID: 36912186
[TBL] [Abstract] [Full Text] [Related]
10. Gene Mutations and Targeted Therapies of Myeloid Sarcoma.
Fu L; Zhang Z; Chen Z; Fu J; Hong P; Feng W
Curr Treat Options Oncol; 2023 Apr; 24(4):338-352. PubMed ID: 36877373
[TBL] [Abstract] [Full Text] [Related]
11. Erdheim-Chester Disease with BRAF V600E Mutation and a Concomitant Myeloid Malignancy Sharing NRAS and idh2 Mutations.
Prabhakaran N; Jour G; Balar A; Ward N
Acta Haematol; 2023; 146(3):245-251. PubMed ID: 36754028
[TBL] [Abstract] [Full Text] [Related]
12. Prediction of survival with lower intensity therapy among older patients with acute myeloid leukemia.
Sasaki K; Ravandi F; Kadia TM; Borthakur G; Short NJ; Jain N; Daver NG; Jabbour EJ; Garcia-Manero G; Loghavi S; Patel KP; Montalban-Bravo G; Masarova L; DiNardo CD; Kantarjian HM
Cancer; 2023 Apr; 129(7):1017-1029. PubMed ID: 36715486
[TBL] [Abstract] [Full Text] [Related]
13. Mutational Landscape of Patients Referred for Elevated Hemoglobin Level.
Bhai P; Chin-Yee B; Pope V; Cheong I; Matyashin M; Levy MA; Foroutan A; Stuart A; Hsia CC; Lin H; Sadikovic B; Chin-Yee I
Curr Oncol; 2022 Sep; 29(10):7209-7217. PubMed ID: 36290845
[No Abstract] [Full Text] [Related]
14. Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
Ball S; Knepper TC; Deutsch YE; Samra W; Watts JM; Bradley TJ; Chan O; Hussaini MO; Zhang L; Sweet KL; Kuykendall AT; Talati C; Padron E; Komrokji RS; Lancet JE; Sallman DA
Cancer; 2022 Nov; 128(21):3880-3887. PubMed ID: 36107670
[TBL] [Abstract] [Full Text] [Related]
15. Impact of idh1 and idh2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
Kunadt D; Stasik S; Metzeler KH; Röllig C; Schliemann C; Greif PA; Spiekermann K; Rothenberg-Thurley M; Krug U; Braess J; Krämer A; Hochhaus A; Scholl S; Hilgendorf I; Brümmendorf TH; Jost E; Steffen B; Bug G; Einsele H; Görlich D; Sauerland C; Schäfer-Eckart K; Krause SW; Hänel M; Hanoun M; Kaufmann M; Wörmann B; Kramer M; Sockel K; Egger-Heidrich K; Herold T; Ehninger G; Burchert A; Platzbecker U; Berdel WE; Müller-Tidow C; Hiddemann W; Serve H; Stelljes M; Baldus CD; Neubauer A; Schetelig J; Thiede C; Bornhäuser M; Middeke JM; Stölzel F;
J Hematol Oncol; 2022 Sep; 15(1):126. PubMed ID: 36064577
[TBL] [Abstract] [Full Text] [Related]
16. diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Döhner H; Wei AH; Appelbaum FR; Craddock C; DiNardo CD; Dombret H; Ebert BL; Fenaux P; Godley LA; Hasserjian RP; Larson RA; Levine RL; Miyazaki Y; Niederwieser D; Ossenkoppele G; Röllig C; Sierra J; Stein EM; Tallman MS; Tien HF; Wang J; Wierzbowska A; Löwenberg B
Blood; 2022 Sep; 140(12):1345-1377. PubMed ID: 35797463
[TBL] [Abstract] [Full Text] [Related]
17. Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms.
Kim T; Ahn JS; Son MH; Novitzky-Basso I; Yi SY; Ahn SY; Jung SH; Yang DH; Lee JJ; Choi SH; Lee JY; Moon JH; Sohn SK; Kim HJ; Zhang Z; Kim DDH
Leuk Res; 2022 Jul; 118():106858. PubMed ID: 35609360
[TBL] [Abstract] [Full Text] [Related]
18. Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia.
Chua CC; Hammond D; Kent A; Tiong IS; Konopleva MY; Pollyea DA; DiNardo CD; Wei AH
Blood Adv; 2022 Jul; 6(13):3879-3883. PubMed ID: 35511730
[TBL] [Abstract] [Full Text] [Related]
19. Impact of idh1 and idh2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation.
Bill M; Jentzsch M; Bischof L; Kohlschmidt J; Grimm J; Schmalbrock LK; Backhaus D; Brauer D; Goldmann K; Franke GN; Vucinic V; Niederwieser D; Mims AS; Platzbecker U; Eisfeld AK; Schwind S
Blood Adv; 2023 Feb; 7(3):436-444. PubMed ID: 35381077
[TBL] [Abstract] [Full Text] [Related]
20. What to use to treat AML: the role of emerging therapies.
Thol F
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):16-23. PubMed ID: 34889359
[TBL] [Abstract] [Full Text] [Related]
[Next]
